Managing Treatment for Patients with Relapsed/Refractory Lymphoma

Sonali M. Smith, MD, FASCO, The University of Chicago, Chicago, IL

Recorded on January 25, 2021

How do we start the conversation? How do we discuss patient expectation and the likelihood of relapse? What role does the timing of relapse play? In this episode, Dr. Sonali Smith, the Elwood V. Jensen Professor of Medicine at The University of Chicago, discusses expectations for disease control and for relapse, the mechanisms of resistance, exciting advances in the treatment of relapsed/refractory lymphoma, including new treatments, and so much more. Tune in to this important talk today!

Sonali Smith, MD, FASCO
Sonali Smith, MD, FASCO
Elwood V. Jensen Professor of Medicine
Chief, Section of Hematology/Oncology
Co-Leader, Cancer Service Line
Co-Director, Lymphoma Program
The University of Chicago
Chicago, IL

This podcast episode is supported by Epizyme.

Leave a Reply

Your email address will not be published. Required fields are marked *